Robert H. Underwood is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Boston office. Bob has extensive experience creating and evaluating intellectual property protection in the areas of life sciences and chemistry including antibody-based and other protein therapeutics, nucleic acid and genetic technology, small molecule therapeutics, medicinal chemistry, drug discovery and development, organic chemistry, polymers, catalysts, and drug formulation and delivery. His practice focuses on patent portfolio development and management, patent prosecution, opinions, licensing, due diligence and related counseling. He also assists clients with product planning matters as they relate to intellectual property, patent life-cycle management and the acquisition and divestment of intellectual property assets.
Prior to joining McDermott, Bob was in private practice. He has also been a visiting scientist at the Basel Institute for Immunology in Switzerland and a research associate at Brigham and Women’s Hospital in Boston.
Bob earned his J.D. from Suffolk University Law School, his Ph.D. in immunology from Tufts University and his B.S. in biology from the University of New Hampshire.
Bob is a member of the American Bar Association, the American Intellectual Property Law Association and the Boston Patent Law Association. He is a registered patent attorney admitted to practice before the U.S. Patent and Trademark Office.
Education
- Suffolk University Law School, J.D. (cum laude), 2005
- Tufts University, Ph.D., 1998
- University of New Hampshire, B.S., 1989
